ClinicalTrials.Veeva

Menu

Exercise in Pregnant Women With Gestational Diabetes

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Unknown

Conditions

Gestational Diabetes

Treatments

Behavioral: physical activity

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Gestational diabetes (GDM) impacts 1 in 10 pregnancies; hyperglycemia and hypertriglyceridemia are common features of the condition. Women are recommended to do at least 150 minutes of moderate-intensity aerobic activity a week during pregnancy and the postpartum period. Exercise both during and out of pregnancy has been shown to be an effective non-pharmacologic tool to reduce glucose and lipid profiles. The goals and purpose of this pilot study is to 1) determine the influence of exercise and the timing of exercise surrounding a meal on glucose and lipid metabolism in pregnant women with GDM and 2) determine the feasibility of low-resistance and aerobic activity and measuring exercise metrics during pregnancy. The overarching objective of this study is to determine the effects of low-resistance and aerobic exercise on glucose and lipids following a meal in pregnant women with GDM.

Full description

Gestational diabetes (GDM) impacts 1 in 10 pregnancies; hyperglycemia and hypertriglyceridemia are common features of the condition. Women are recommended to do at least 150 minutes of moderate-intensity aerobic activity a week during pregnancy and the postpartum period. Exercise both during and out of pregnancy has been shown to be an effective non-pharmacologic tool to reduce glucose and lipid profiles. The goals and purpose of this pilot study is to 1) determine the influence of exercise and the timing of exercise surrounding a meal on glucose and lipid metabolism in pregnant women with GDM and 2) determine the feasibility of low-resistance and aerobic activity and measuring exercise metrics during pregnancy. The overarching objective of this study is to determine the effects of low-resistance and aerobic exercise on glucose and lipids following a meal in pregnant women with GDM. Women will perform either low-resistance or aerobic exercise. Blood will be taken before and 2 hours after a fixed meal. For safety, women will have supervised exercise and oxygen consumption will be measured throughout the activity.

Enrollment

12 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diet and lifestyle controlled gestational diabetes
  • Gestational age 28 weeks-32 weeks gestation
  • Age 18-50 years
  • Singleton pregnancy

Exclusion criteria

  • Chronic hypertension
  • Pregestational diabetes
  • History of peripartum cardiomyopathy
  • Any condition contraindicating for exercise
  • Taking any cardiovascular modifying medications (beta-blockers, calcium channel blockers, corticosteroids)
  • Asthma or other underlying lung disease that is equivalent or worse than persistent mild classification (defined as at least >2 day/week asthmatic symptoms, 1-2x/month nighttime awakenings, >2days/week short-acting beta-agonist use for symptom control, and minor limitations with normal activity; ≥2 exacerbations in 6 months requiring oral systemic corticosteroids, ≥4 wheezing episodes/1 year lasting >1 day)
  • Congenital anomalies
  • Multifetal gestation
  • Current alcohol use
  • Current tobacco use

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 2 patient groups

low-resistance
Experimental group
Description:
women will perform low-resistance physical activity
Treatment:
Behavioral: physical activity
aerobic
Experimental group
Description:
women will perform aerobic physical activity
Treatment:
Behavioral: physical activity

Trial contacts and locations

1

Loading...

Central trial contact

Amy M Valent, DO; Michaela Rickert, PA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems